Company profile: Trials24
1.1 - Company Overview
Company description
- Provider of online patient recruitment solutions for clinical trials worldwide, helping CROs and biopharmaceutical companies find patients beyond site databases. Offers OutSite Patient Recruitment leveraging online platforms and patient organizations, and OutSite Feasibility to assess patient availability before trials, reducing recruitment time by 6+ months with 7–12x ROI and providing 20–65% of randomized patients.
Products and services
- OutSite™ Patient Recruitment: Global-scale service recruiting patients beyond site databases via online platforms and patient organizations, cutting recruitment time by 6+ months and delivering 20–65% randomized patients, with 7–12x ROI
- Worldwide Online Patient Recruitment Acceleration: Online-first service accelerating trial enrollment globally for CROs and biopharma, finding patients sites can’t reach and reducing recruitment time by 6+ months with 7–12x ROI
- OutSite™ Feasibility: Pretrial service assessing patient availability for a clinical study before start, delivering recruitment certainty for CROs and biopharmaceutical sponsors seeking patients sites can’t reach.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trials24
Dana Solutions
HQ: United States
Website
- Description: Provider of applications of artificial intelligence and machine learning to in vitro cell-based assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dana Solutions company profile →
Inova
HQ: France
Website
- Description: Provider of digital partnering solutions for the biopharma and life sciences industry, offering Inpart, a platform connecting academic researchers, universities and industry to facilitate collaboration and commercialization; Connect, an algorithm- and machine learning–based matchmaking platform aligning biotech assets with biopharma needs; Deal, a CRM for biopharma partnering; and Event, software for managing in-person or online life science conferences and meetings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inova company profile →
NetraMark
HQ: Canada
Website
- Description: Provider of AI-driven pharma-tech solutions for pharmaceutical and biotechnology companies, enabling the use of small to large datasets to optimize clinical trials and drug development through superior understanding of patient populations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NetraMark company profile →
ChemNavigator
HQ: United States
Website
- Description: Provider of tools and services for scientists to find and procure chemistry for drug discovery, supporting research organizations in the United States and internationally. Offers the ChemNavigator platform to identify and procure chemistry for drug discovery and agrochemical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemNavigator company profile →
Aperio
HQ: United States
Website
- Description: Provider of digital pathology solutions for hospitals, reference labs, and pharmaceutical and research institutions across the world, offering an affordable, complete portfolio that enhances quality assurance, delivers more efficient workflows, and improves patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aperio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trials24
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trials24
2.2 - Growth funds investing in similar companies to Trials24
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trials24
4.2 - Public trading comparable groups for Trials24
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →